Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Nephrol ; 75 Suppl 1: 4-10, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21269585

RESUMO

We describe the clinical course of a female adolescent who was followed because of isolated microhematuria and hypocomplementemia before admission to hospital with a sudden onset of acute renal failure. At presentation, she exhibited complement consumption through the complement alternative pathway (AP) while other serologic tests were negative. Renal biopsy revealed dense deposit disease (DDD) with a crescentic pattern. Intravenous methylprednisolone, followed by plasma exchange (PE), and intravenous cyclophosphamide pulses were started shortly after admission. C3NeF and anti-factor H antibody tests were negative. Serum factor H and I levels were normal as well as factor H activity. Screening for mutation in the factor H gene revealed the H402 allele variant. Clinical remission, defined as normalization in renal function and in the activity levels of the complement AP, was noted at one month post-presentation and throughout the follow-up. A repeat renal biopsy showed the disappearance of crescent formation, whereas electron microscopy revealed no regression in dense transformation of the lamina densa. In summary, our patient was successfully treated with immunosuppressant and PE. The absence of known factors associated with DDD suggests that, in this particular case, other regulatory mechanisms of complement AP might have been involved in the disease process.


Assuntos
Injúria Renal Aguda/terapia , Ciclofosfamida/uso terapêutico , Glomerulonefrite Membranoproliferativa/terapia , Imunossupressores/uso terapêutico , Metilprednisolona/uso terapêutico , Troca Plasmática , Injúria Renal Aguda/genética , Injúria Renal Aguda/imunologia , Injúria Renal Aguda/patologia , Adolescente , Biópsia , Terapia Combinada , Ativação do Complemento , Fator H do Complemento/genética , Ciclofosfamida/administração & dosagem , Análise Mutacional de DNA , Quimioterapia Combinada , Feminino , Glomerulonefrite Membranoproliferativa/genética , Glomerulonefrite Membranoproliferativa/imunologia , Glomerulonefrite Membranoproliferativa/patologia , Humanos , Imunossupressores/administração & dosagem , Metilprednisolona/administração & dosagem , Mutação , Pulsoterapia , Resultado do Tratamento
2.
Pediatr Nephrol ; 11(4): 502-3, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9260257

RESUMO

The syndrome of inappropriate secretion of antidiuretic hormone (ADH) or SIADH has been reported in various disorders. We report a pediatric patient with nasopharynx carcinoma who may have developed a clinical SIADH with severe hyponatremia and generalized seizure during the administration of intravenous hydration. We propose that the inappropriately high plasma level of ADH led to the inability to excrete sufficient amounts of free water during a hyperhydration protocol with a relatively hypotonic fluid, which resulted in acute hyponatremia and central nervous system involvement. To avoid this complication, intravenous hydration before chemotherapy in children with nasopharynx carcinoma should be performed at a slower infusion rate and with a sodium chloride concentration of more than half isotonic.


Assuntos
Síndrome de Secreção Inadequada de HAD/etiologia , Neoplasias Nasofaríngeas/complicações , Criança , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA